These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1682327)

  • 41. Long term mortality in critically ill burn survivors.
    Nitzschke S; Offodile AC; Cauley RP; Frankel JE; Beam A; Elias KM; Gibbons FK; Salim A; Christopher KB
    Burns; 2017 Sep; 43(6):1155-1162. PubMed ID: 28606748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the role of alternative therapy in burn wound management: randomized trial comparing moist exposed burn ointment with conventional methods in the management of patients with second-degree burns.
    Ang ES; Lee ST; Gan CS; See PG; Chan YH; Ng LH; Machin D
    MedGenMed; 2001 Mar; 3(2):3. PubMed ID: 11549952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Management of Itching in Burn Patients During the Rehabilitation Stage].
    Lo SF; Chang LJ; Shiue TY; Pan CY; Wu HC
    Hu Li Za Zhi; 2016 Dec; 63(6):102-106. PubMed ID: 27900750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attribution bias underlying burns-induced anxiety symptoms.
    Farag M; Watson EJR; Nenadlová K; Asher C; Al-Aidarous S; Mandalia S; Williams LM; Edginton TL; Collins D; Vizcaychipi MP
    Burns; 2018 Sep; 44(6):1502-1508. PubMed ID: 29886115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes of isolated lower extremity or foot burns in diabetic versus non-diabetic patients: a 10-year retrospective analysis.
    Kimball Z; Patil S; Mansour H; Marano MA; Petrone SJ; Chamberlain RS
    Burns; 2013 Mar; 39(2):279-84. PubMed ID: 22789396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic ondansetron does not reduce the incidence of itching induced by intrathecal sufentanil.
    Waxler B; Mondragon SA; Patel SN; Nedumgottil K
    Can J Anaesth; 2004; 51(7):685-9. PubMed ID: 15310636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial.
    Gobo-Oliveira M; Pigari VG; Ogata MS; Miot HA; Ponce D; Abbade LP
    Eur J Dermatol; 2018 Aug; 28(4):488-495. PubMed ID: 29976533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
    Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
    Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of porcine acellular dermal matrix following early dermabrasion reduces length of stay in extensive deep dermal burns.
    Guo ZQ; Qiu L; Gao Y; Li JH; Zhang XH; Yang XL; Peszel A; Chen XL
    Burns; 2016 May; 42(3):598-604. PubMed ID: 26777449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pruritus in burns: review article.
    Goutos I; Dziewulski P; Richardson PM
    J Burn Care Res; 2009; 30(2):221-8. PubMed ID: 19165110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
    Zirwas MJ; Barkovic S
    J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema.
    Savin JA; Dow R; Harlow BJ; Massey H; Yee KF
    Clin Exp Dermatol; 1986 Nov; 11(6):600-2. PubMed ID: 2889550
    [No Abstract]   [Full Text] [Related]  

  • 53. The use of antihistamines with a low sedative potential in the treatment of the itching of atopic eczema.
    Gibson JR
    Clin Exp Dermatol; 1987 Nov; 12(6):469-70. PubMed ID: 2904843
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of pain Scrambler therapy for management of burn scar pruritus: A pilot study.
    Joo SY; Cho YS; Cho SR; Kym D; Seo CH
    Burns; 2017 May; 43(3):514-519. PubMed ID: 27756587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased expression of three types of transient receptor potential channels (TRPA1, TRPV4 and TRPV3) in burn scars with post-burn pruritus.
    Yang YS; Cho SI; Choi MG; Choi YH; Kwak IS; Park CW; Kim HO
    Acta Derm Venereol; 2015 Jan; 95(1):20-4. PubMed ID: 24695993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
    Mathur VS; Kumar J; Crawford PW; Hait H; Sciascia T;
    Am J Nephrol; 2017; 46(6):450-458. PubMed ID: 29253847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impairment of tear film and the ocular surface in patients with facial burns.
    Choi SO; Chung TY; Shin YJ
    Burns; 2017 Dec; 43(8):1748-1756. PubMed ID: 28511872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aquagenic pruritus.
    Steinman HK; Greaves MW
    J Am Acad Dermatol; 1985 Jul; 13(1):91-6. PubMed ID: 2411768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multicenter epidemiological investigation of hospitalized elderly, young and middle-aged patients with severe burn].
    Tang Y; Wang LX; Xie WG; Shen ZA; Guo GH; Chen JJ; Han CM; Ren LC; Chu ZG; Yin MF; Wang Y; Zhang DX; Huang YS; Zhang JP
    Zhonghua Shao Shang Za Zhi; 2017 Sep; 33(9):537-544. PubMed ID: 28926874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.